HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: M600261-MCP200v1 6/6/1039    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Andersen, C. L. Articles by Ørntoft, T. F. Search for Related Content PubMed PubMed Citation Articles by Andersen, C. L. Articles by Ørntoft, T. F. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 6:1039-1048, 2007.
© 2007 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Research

Clusterin Expression in Normal Mucosa and Colorectal Cancer^*,S

Claus Lindbjerg Andersen^,, Troels Schepeler, Kasper Thorsen, Karin Birkenkamp-Demtröder, Francisco Mansilla, Lauri A. Aaltonen^¶, Søren Laurberg^|| and Torben Falck Ørntoft^,**

From the Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, DK8200 Aarhus N, Denmark, ^¶ Department of Medical Genetics, Biomedicum, University of Helsinki, FIN-00014 Helsinki, Finland, and ^|| Department of Surgery, Aarhus University Hospital, DK8000 Aarhus C, Denmark

The gene Clusterin is a target for cancer therapy in clinical trials. The indication for intervention is up-regulated Clusterin expression. Clusterin has been reported to be deregulated in multiple cancer types, including colorectal cancer (CRC). However, for CRC the studies have disagreed on whether Clusterin is up- or down-regulated by neoplastic cells. In the present study we sought to clarify the expression and distribution of Clusterin mRNAs and proteins in normal and neoplastic colorectal tissue through laser microdissection, variant-specific real time RT-PCR, immunohistochemistry, immunofluorescence, Western blotting, and array-based transcriptional profiling. At the transcript level we demonstrated the expression of two novel Clusterin transcripts in addition to the known transcript, and at the protein level we demonstrated two Clusterin isoforms. Our analysis of normal epithelial cells revealed that among these, Clusterin was only expressed by rare neuroendocrine subtype. Furthermore our analysis showed that in the normal mucosa the majority of the observed Clusterin protein originated from the stromal compartment. In tumors we found that Clusterin was de novo synthesized by non-neuroendocrine cancer cells in 25% of cases. Moreover we found that the overall Clusterin level in tumors often appeared to be lower than in normal mucosa due to the stromal compartment often being suppressed in tumors. Although Clusterin in normal neuroendocrine cells showed a basal localization, the localization in cancer cells was often apical and in some cases associated with apical secretion. Collectively our results indicate that Clusterin expression is very complex. We conclude that Clusterin expression is associated with neuroendocrine differentiation in normal epithelia and that the Clusterin observed in neoplastic cells is de novo synthesized. The cases with de novo synthesized Clusterin define a distinct subgroup of CRC that may be of clinical importance as anti-Clusterin therapeutics are now in clinical trials.

^** To whom correspondence may be addressed: Molecular Diagnostic Laboratory, Dept. of Clinical Biochemistry, Aarhus University Hospital, Skejby, DK8200 Aarhus N, Denmark. Tel.: 45-89495195; Fax: 45-89496018; E-mail: orntoft{at}ki.au.dk

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Thorsen, K. D. Sorensen, A. S. Brems-Eskildsen, C. Modin, M. Gaustadnes, A.-M. K. Hein, M. Kruhoffer, S. Laurberg, M. Borre, K. Wang, et al. Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis Mol. Cell. Proteomics, July 1, 2008; 7(7): 1214 - 1224. [Abstract] [Full Text] [PDF]